Rock the House—from Silicon Valley to China

It’s that time of the quarter, when venture capital fundraising data are released by the National Venture Capital Association (NVCA), possibly leaving all the sophisticated investors across the industry wringing their collective hands about frothiness. The latest data shows that VCs in 2Q15 raised over $10.4 billion (slightly revised upward from the amount first announced earlier this month) across 74 funds—this is a 39 percent step-up from the amount raised in 1Q15 and a 27 percent increase from 2Q14. This is the largest amount raised since 4Q07—do you remember what happened in 2008? Wow.

As usual, the headlines tend to mask some important developments one sees when wading through the data. The VC industry continues to consolidate around a limited number of managers who raise large funds with large Roman numerals attached to them. There continues to be evidence that limited partners will occasionally support smaller, very focused funds, but the land of mid-sized funds continues to shrink; only 9 of the 74 funds were between $100million and $300 million in size (disclosure: my firm—Flare Capital Partners—announced this quarter a $200 million fund which we believe is ideally suited to focus intensely on early stage opportunities, yet be “life cycle” investors who support our entrepreneurs across every round).

On a trailing quarter annualized basis the VC industry is tracking to raise $40 billion this year, which would be the most raised in nearly 15 years. A related announcement last Friday on investment data showed that VCs invested $17.5 billion in 2Q15, implying an annual investment pace of nearly $70 billion. This $30 billion projected “funding gap” for 2015 is largely filled by non-VC investors (hedge funds, corporates, sovereign wealth funds, mutual funds), who arguably are looking for greater returns than what is available elsewhere in other asset classes. The question this begs is, How will these investors behave when the tide inevitably turns? The other concern imbedded in all of this is one of absorption—that is, can the VC industry “productively” deploy $35 billion across 4,000-odd companies this year?

As of the end of 2014, the NVCA estimated that the VC industry had about $160 billion of assets under management. Over the last 15 years, the industry was well in excess of $200 billion in size. But given that some firms could not raise funds during the recession, and many funds that did were much smaller than they had been, the industry naturally shrunk. The concern I have is that it might expand again too rapidly.

LP_graph_large

Now for some interesting nuggets from the detailed data in the fundraising reports:

  • Of the 74 funds raised, 31 (42 percent) were considered “new funds,” but these only raised $1.3 billion or 13 percent of the total
  • Average size of “new funds” is $43 million, which is overshadowed by the $212 million average size of the “follow-on” funds raised—clearly success begets success
  • The largest “new fund” raised, Geodesic Capital, was $250 million, while New Enterprise Associates raised the largest overall fund of $2.8 billion (not counting a separate $350 million side-car fund)—so limited partners will dabble with new managers but just not too much
  • The Top 10 funds raised $7.2 billion or 70 percent of the capital attracted in 2Q15
  • The Bottom 10 raised $14.3 million or 0.14 percent of the capital—not a typo
  • Seven of the Top 10 funds are based in California and represent $6.3 billion
  • In fact, overall, California funds accounted for $7.7 billion or 74 percent of capital raised
  • And while 18 states were represented on the list, outside of California, Massachusetts, and New York, fund managers in those other 15 states raised just $1.1 billion or 11 percent of the capital

California, specifically Silicon Valley, always leads the way—typically about 60 percent of all dollars raised are invested each year in California-based companies. What is notable here is the extreme level of concentration of the underlying fund managers. When so much of the capital is managed in a single geography, are we at risk of creating an “echo chamber” that drives herd/irrational behavior? Does this naturally lead to the overfunding of new categories as each firm wants its own portfolio company in a given category?

And as a point of comparison, given that I grew up in Hong Kong and remain fascinated about the emerging capital markets in China, that market always provides a provocative juxtaposition. The last few years have ushered in extraordinary change in China: the capital flows are staggering and now so are the volatility and issues of absorption—will VCs start too many undifferentiated companies? Some interesting—almost unbelievable—data coming out of China this past quarter:

  • 4,000 new hedge funds were launched in 2Q15, mostly focused on equity investments, and funded principally by the emerging class of 90 million new retail—aka individual—investors
  • There are now 12,285 hedge funds in China employing 199,000 people, according to the China securities regulatory authorities
  • Year-to-date 2015, $452 billion of public and private equity – that is billion with a “b” – was raised in China, according to J Capital Research
  • There is estimated to be $320 billion of short-term margin loans outstanding; these typically have a 6-month duration, much of them held by these new retail investors—now, with these loans beginning to come due, the recent volatility in the Chinese stock exchanges starts to make more sense.  Citigroup estimated that some $4 trillion of equity valued was lost—this is twice the size of India’s economy
  • That is nothing, though—$8.5 trillion of debt has been issued in China year-to-date, and when combined with the $1.1 trillion of corporate bonds issued, this brings the total China debt load to over $28 trillion

Now that will be fun to watch play out…

Author: Michael A. Greeley

Michael is a General Partner at Flare Capital Partners. Prior to co-founding Flare Capital Partners, Michael was the founding General Partner of Flybridge Capital Partners where he led the firm’s healthcare investments. Current and prior board seats include BlueTarp Financial, Circulation, EndoGastric Solutions, Explorys, Functional Neuromodulation, HealthVerity, Iora Health, MicroCHIPS, Nuvesse, PolyRemedy, Predictive Biosciences, Predilytics, T2 Biosystems, TARIS Biomedical, VidSys and Welltok. Previously, Michael focused on emerging-growth company financings with Polaris Venture Partners, was a senior vice president and founding partner of GCC Investments, and held positions at Wasserstein Perella & Co., Morgan Stanley & Co. and Credit Suisse First Boston. Michael currently serves as chairman of the Entrepreneurship Committee of the Massachusetts Information Collaborative and on the Investment Committee for the Partners Innovation Fund and Massachusetts Eye & Ear Infirmary. Michael also serves on the Industry Advisory Board of the Cleveland Clinic and Boston Children’s Hospital, as well as serving on several other boards including the New England Investors’ Committee of Capital Innovation. He was the former chairman of the New England Venture Capital Association and on the Executive Committee of the board of the National Venture Capital Association. Named by the Boston Globe as the “Go-To” investor for life sciences, healthcare and medical devices and a Mass High Tech All-Star, Michael earned a B.A. with honors in chemistry from Williams College and an M.B.A. from Harvard Business School. Michael authors a blog focused on venture capital, innovation and healthcare at www.ontheflyingbridge.com.